H1 is the first company to arm healthcare and life science companies with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

H1 enables industry, healthcare organizations, and healthcare professionals to connect with each other like never before.

H1 was founded in 2017 by Ariel Katz and Ian SaxIan Sax. The company is headquartered in New York, New York.

 

H1 has built the premier healthcare data network for Healthcare Providers (HCPs), searching scholarly data and medical claims data to surface the most relevant researchers or clinicians given any criteria.

 

H1's platform helps life sciences companies, hospitals, academic medical centers and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organizations.

 

H1’s platform comprises over 8 million researcher, physician, pharmacist, nurse, and administrator profiles across 70 countries, 16,000 health care organizations, 160 million peer-reviewed publications (and citation counts), 350,000 clinical trials, 2 billion procedures, 3 billion diagnoses, 700 medical societies.

 

H1 is backed by Altimeter Capital, Menlo Ventures, IVP, Lux Capital, Goldman Sachs Asset Management, Lead Edge Capital, Novartis DRX, Flex Capital, ClearPoint Investment, and others. The company raised $100M in Series C round on Nov 16, 2021. This brings H1's total funding to $176.9M to date.

 

 

  • Year founded: 2017
  • Funding Info: $176.9M over 5 Rounds (Latest Funding Type: Series C)
  • Yearly Revenue: NA
  • Employee Size: 201-500
  • Business Valuation: NA
  • City/Town: New York
  • State: New York
  • Country: United States
Related businesses